02652 CF PHARMTECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 4.59X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 6.8% | Net Margin | 0.6% |
| Total Debt/Equity | 9.9% | Return on Equity | 0.2% |
| Price/Book | 5.75X | Return on Assets | 0.1% |
| (HKD 22.800) | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | 2.77 | 22.43 | 34.97 | -55.39 |
|---|---|---|---|---|
| Net Profit Growth (%) | -87.7 | -35.9 | +163.1 | N/A |
| Earnings Per Share (HKD) | 0.007 | 0.061 | 0.094 | -0.149 |
| Earnings Per Share Growth (%) | -87.9 | -35.8 | +163.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 3,123.29 | 376.86 | 241.78 | N/A |
| Yield (%) | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 3.968 | N/A | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 432.521 | 607.752 | -28.8 | 556.421 |
| Operating Result | -13.237 | 19.258 | -168.7 | 22.542 |
| Associates | -0.17 | -0.074 | +129.7 | -0.099 |
| Profit Before Taxation | -13.407 | 19.184 | -169.9 | 22.443 |
| Taxation | -15.892 | -1.904 | +734.7 | -9.283 |
| Profit /( Loss) After Taxation | 2.485 | 21.088 | -88.2 | 31.726 |
| Net Profit | 2.485 | 21.088 | -88.2 | 31.726 |
| Earnings Per Share () | 0.0073 | 0.0605 | -87.9 | 0.0943 |
| Announcement Date | 2026-03-30 | 2025-09-26 | NA | 2025-09-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
